v3.25.2
Report of the directors financial review risk report (Tables)
6 Months Ended
Jun. 30, 2025
Report Of The Directors Financial Review Risk Report [Abstract]  
Disclosure of detailed information about financial instruments Summary of credit risk
The following disclosure presents the gross carrying/nominal amount of financial instruments to which the impairment requirements in IFRS 9
are applied and the associated allowance for ECL.
The following tables analyse loans by industry sector and represent the concentration of exposures on which credit risk is managed.
Summary of financial instruments to which the impairment requirements in IFRS 9 are applied
At 30 Jun 2025
At 31 Dec 2024
Gross carrying/
nominal amount
Allowance for
ECL1
Gross carrying/
nominal amount
Allowance for
ECL1
£m
£m
£m
£m
Loans and advances to customers at amortised cost
79,551
(670)
83,524
(858)
Loans and advances to banks at amortised cost
15,806
(3)
14,524
(3)
Other financial assets measured at amortised cost
244,062
(6)
237,475
(6)
–  cash and balances at central banks
96,155
119,184
–  reverse repurchase agreements – non-trading
68,408
53,612
–  financial investments
14,953
12,226
–  assets held for sale
3,473
(3)
2,591
(3)
–  prepayments, accrued income and other assets2
61,073
(3)
49,862
(3)
Total on-balance sheet
339,419
(679)
335,523
(867)
Loans and other credit-related commitments
145,621
(46)
121,764
(49)
Financial guarantees3
2,855
(4)
2,876
(9)
Total off-balance sheet4
148,476
(50)
124,640
(58)
487,895
(729)
460,163
(925)
Fair value
Memorandum
allowance for
ECL5
Fair value
Memorandum
allowance for
ECL5
£m
£m
£m
£m
Debt instruments measured at fair value through other comprehensive income
(‘FVOCI’)
52,547
(26)
46,649
(22)
–  of which: assets held for sale
11,574
6,776
1The total ECL is recognised in the loss allowance for the financial asset unless the total ECL exceeds the gross carrying amount of the financial asset, in which
case the ECL is recognised as a provision.
2Includes only those financial instruments that are subject to the impairment requirements of IFRS 9. ‘Prepayments, accrued income and other assets’ as
presented within the consolidated balance sheet on page 31 comprises both financial and non-financial assets, including cash collateral and settlement
accounts.
3Excludes performance guarantee contracts to which the impairment requirements in IFRS 9 are not applied.
4Represents the maximum amount at risk should the contracts be fully drawn upon and clients default.
5Debt instruments measured at FVOCI continue to be measured at fair value with the allowance for ECL as a memorandum item. Change in ECL is recognised in
‘Change for expected credit losses and other credit impairment charges’ in the income statement.
Disclosure of credit risk
Summary of credit risk (excluding debt instruments measured at FVOCI) by stage distribution and ECL coverage by industry sector at 30 June
2025
Gross carrying/nominal amount1
Allowance for ECL
ECL coverage %
Stage 1
Stage 2
Stage 3
POCI2
Total
Stage 1
Stage 2
Stage 3
POCI2
Total
Stage 1
Stage 2
Stage 3
POCI2
Total
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
%
%
%
%
%
Loans and
advances to
customers at
amortised cost
72,761
5,051
1,700
39
79,551
(68)
(103)
(481)
(18)
(670)
0.1
2.0
28.3
46.2
0.8
–  personal
13,401
766
295
14,462
(13)
(14)
(86)
(113)
0.1
1.8
29.2
0.8
–  corporate and
commercial
41,803
3,703
1,301
39
46,846
(44)
(84)
(372)
(18)
(518)
0.1
2.3
28.6
46.2
1.1
–  non-bank
financial
institutions
17,557
582
104
18,243
(11)
(5)
(23)
(39)
0.1
0.9
22.1
0.2
Loans and
advances to
banks at
amortised cost
15,752
53
1
15,806
(1)
(1)
(1)
(3)
1.9
100.0
Other financial
assets
measured at
amortised cost
243,979
48
35
244,062
(3)
(3)
(6)
8.6
Loans and other
credit-related
commitments
142,777
2,701
140
3
145,621
(17)
(15)
(14)
(46)
0.6
10.0
–  personal
1,050
27
2
1,079
–  corporate and
commercial
60,314
2,361
136
3
62,814
(13)
(14)
(13)
(40)
0.6
9.6
0.1
–  financial
81,413
313
2
81,728
(4)
(1)
(1)
(6)
0.3
50.0
Financial
guarantees
2,582
229
44
2,855
(1)
(1)
(2)
(4)
0.4
4.5
0.1
–  personal
124
1
125
–  corporate and
commercial
1,102
176
44
1,322
(1)
(1)
(2)
(4)
0.1
0.6
4.5
0.3
–  financial
1,356
52
1,408
At 30 Jun 2025
477,851
8,082
1,920
42
487,895
(90)
(120)
(501)
(18)
(729)
1.5
26.1
42.9
0.1
1Represents the maximum amount at risk should the contracts be fully drawn upon and clients default.
2Purchased or originated credit impaired (‘POCI‘).
Summary of credit risk (excluding debt instruments measured at FVOCI) by stage distribution and ECL coverage by industry sector at
31 December 2024 (continued)
Gross carrying/nominal amount2
Allowance for ECL
ECL coverage %
Stage 1
Stage 2
Stage 3
POCI
Total
Stage 1
Stage 2
Stage 3
POCI
Total
Stage 1
Stage 2
Stage 3
POCI
Total
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
%
%
%
%
%
Loans and
advances to
customers at
amortised cost
75,844
5,546
2,096
38
83,524
(56)
(107)
(677)
(18)
(858)
0.1
1.9
32.3
47.4
1.0
–  personal
18,733
955
259
19,947
(14)
(19)
(79)
(112)
0.1
2.0
30.5
0.6
–  corporate and
commercial
41,386
4,375
1,628
38
47,427
(35)
(85)
(454)
(18)
(592)
0.1
1.9
27.9
47.4
1.2
–  non-bank
financial
institutions
15,725
216
209
16,150
(7)
(3)
(144)
(154)
1.4
68.9
1.0
Loans and
advances to
banks at
amortised cost
14,457
67
14,524
(2)
(1)
(3)
1.5
Other financial
assets measured
at amortised
cost
237,375
59
41
237,475
(4)
(2)
(6)
4.9
Loan and other
credit-related
commitments
116,787
4,812
162
3
121,764
(14)
(24)
(11)
(49)
0.5
6.8
–  personal
1,149
4
2
1,155
–  corporate and
commercial
58,281
3,775
146
3
62,205
(12)
(22)
(10)
(44)
0.6
6.8
0.1
–  financial
57,357
1,033
14
58,404
(2)
(2)
(1)
(5)
0.2
7.1
Financial
guarantees1
2,763
69
44
2,876
(2)
(1)
(6)
(9)
0.1
1.4
13.6
0.3
–  personal
130
1
131
–  corporate and
commercial
1,288
43
43
1,374
(2)
(1)
(5)
(8)
0.2
2.3
11.6
0.6
–  financial
1,345
25
1
1,371
(1)
(1)
100.0
0.1
At 31 Dec 2024
447,226
10,553
2,343
41
460,163
(78)
(133)
(696)
(18)
(925)
1.3
29.7
43.9
0.2
1Excludes performance guarantee contracts to which the impairment requirements in IFRS 9 are not applied.
2Represents the maximum amount at risk should the contracts be fully drawn upon and clients default.
Loans and advances to customers and banks measured at amortised cost
At 30 Jun 2025
At 31 Dec 2024
Total gross loans
and advances
Allowance for
ECL
Total gross loans
and advances
Allowance for
ECL
£m
£m
£m
£m
As reported
95,357
(673)
98,048
(861)
Reported in ‘Assets held for sale’
1,575
(3)
887
(3)
Total
96,932
(676)
98,935
(864)
Disclosure of financial assets
Stage 2 days past due analysis at 30 June 2025
Gross carrying amount
Allowance for ECL
ECL coverage %
of which:
of which:
of which:
of which:
of which:
of which:
Stage 2
1 to 29
DPD1,2
30 and >
DPD1,2
Stage 2
1 to 29
DPD1,2
30 and >
DPD1,2
Stage 2
1 to 29
DPD1,2
30 and >
DPD1,2
£m
£m
£m
£m
£m
£m
%
%
%
Loans and advances to customers at
amortised cost
5,051
45
38
(103)
(1)
(1)
2.0
2.2
2.6
–  personal
766
43
11
(14)
(1)
(1)
1.8
2.3
9.1
–  corporate and commercial
3,703
2
25
(84)
2.3
–  non-bank financial institutions
582
2
(5)
0.9
Loans and advances to banks at
amortised cost
53
(1)
1.9
Other financial assets measured at
amortised cost
48
1Up-to-date accounts in stage 2 are not shown in amounts presented above.
2The days past due amounts are presented on a contractual basis.
Stage 2 days past due analysis at 31 December 2024 (continued)
Gross carrying amount
Allowance for ECL
ECL coverage %
of which:
of which:
of which:
of which:
of which:
of which:
Stage 2
1 to 29
DPD1,2
30 and >
DPD1,2
Stage 2
1 to 29
DPD1,2
30 and >
DPD1,2
Stage 2
1 to 29
DPD1,2
30 and >
DPD1,2
£m
£m
£m
£m
£m
£m
%
%
%
Loans and advances to customers at
amortised cost
5,546
81
48
(107)
(3)
(1)
1.9
3.7
2.1
–  personal
955
74
19
(19)
(3)
(1)
2.0
4.1
5.3
–  corporate and commercial
4,375
6
28
(85)
1.9
–  non-bank financial institutions
216
1
1
(3)
1.4
Loans and advances to banks at
amortised cost
67
(1)
1.5
Other financial assets measured at
amortised cost
59
1Up-to-date accounts in stage 2 are not shown in amounts presented above.
2The days past due amounts presented above are on a contractual basis.
Disclosure of macroeconomic variables and probabilities The following table describes key macroeconomic variables in the consensus Central scenario.
Consensus Central scenario 3Q25-2Q30 (as at 2Q25)
UK
France
GDP (annual average growth rate, %)
2025
0.9
0.5
2026
1.2
1.0
2027
1.5
1.3
2028
1.5
1.3
2029
1.5
1.2
5-year average1
1.4
1.1
Unemployment rate (%)
2025
4.6
7.6
2026
4.7
7.7
2027
4.5
7.5
2028
4.3
7.4
2029
4.1
7.2
5-year average1
4.4
7.5
House prices (annual average growth rate, %)
2025
3.5
2.1
2026
1.2
4.3
2027
2.4
4.9
2028
3.3
4.1
2029
2.7
3.3
5-year average1
2.4
3.9
Inflation (annual average growth rate, %)
2025
3.0
1.3
2026
2.3
1.6
2027
2.0
1.9
2028
2.1
2.3
2029
2.0
2.2
5-year average1
2.2
1.9
Central bank policy rate (annual average, %)
2025
4.2
2.1
2026
3.7
1.6
2027
3.7
1.9
2028
3.8
2.2
2029
3.9
2.4
5-year average1
3.8
2.1
1The five-year average is calculated over the 20 quarter projection.
Consensus Central scenario 2025–2029 (as at 4Q24)
UK
France
GDP (annual average growth rate, %)
2025
1.2
0.9
2026
1.3
0.9
2027
1.8
1.4
2028
1.6
1.5
2029
1.6
1.4
5-year average1
1.5
1.2
Unemployment rate (%)
2025
4.9
7.5
2026
4.7
7.3
2027
4.5
7.2
2028
4.3
7.0
2029
4.3
7.0
5-year average1
4.5
7.2
House prices (annual average growth rate, %)
2025
1.4
2.1
2026
3.8
4.4
2027
4.6
4.4
2028
3.5
3.8
2029
2.7
3.1
5-year average1
3.2
3.6
Inflation (annual average growth rate, %)
2025
2.4
1.2
2026
2.1
1.6
2027
2.1
2.0
2028
2.0
2.3
2029
2.0
2.2
5-year average1
2.1
1.9
Central bank policy rate (annual average, %)
2025
4.2
2.1
2026
3.9
1.8
2027
3.8
2.0
2028
3.7
2.0
2029
3.7
2.1
5-year average1
3.9
2.0
1The five-year average is calculated over the 20 quarter projection.
Consensus Upside scenario (3Q25-2Q30)
UK
France
GDP level (%, start-to-peak)1
11.0
(2Q30)
8.4
(2Q30)
Unemployment rate (%, min)2
3.0
(1Q27)
6.6
(2Q27)
House price index (%, start-to-
peak)1
18.2
(2Q30)
23.3
(2Q30)
Inflation rate (YoY % change,
max)3
3.3
(4Q25)
2.3
(4Q27)
Central bank policy rate (%,
max)3
4.3
(3Q25)
2.5
(2Q30)
Consensus Upside scenario 2025–2029 (as at 4Q24)
UK
France
GDP level (%, start-to-peak)1
11.3
(4Q29)
8.9
(4Q29)
Unemployment rate (%, min)2
3.5
(3Q26)
6.4
(4Q26)
House price index (%, start-to-
peak)1
24.2
(4Q29)
22.8
(4Q29)
Inflation rate (YoY % change,
min)3
1.4
(1Q26)
0.1
(4Q25)
Central bank policy rate (%,
min)3
3.6
(4Q25)
1.4
(3Q25)
1Cumulative change to the highest level of the series during the 20-quarter
projection.
2Lowest projected unemployment in the scenario.
3Highest/lowest projected policy rate and year-on-year percentage change in
inflation in the scenario.
Consensus Downside scenario (3Q25-2Q30)
UK
France
GDP level (%, start-to-trough)1
(0.9)
(3Q27)
(0.6)
(1Q26)
Unemployment rate (%, max)2
6.2
(3Q26)
8.8
(1Q26)
House price index (%, start-to-
trough)1
(6.4)
(4Q26)
0.2
(3Q25)
Inflation rate (YoY % change)3
1.3
(2Q26)
0.6
(2Q26)
Central bank policy rate (%)3
2.4
(1Q28)
0.4
(1Q26)
Consensus Downside scenario 2025–2029 (as at 4Q24)
UK
France
GDP level (%, start-to-trough)1
(1.0)
(4Q26)
(0.6)
(1Q26)
Unemployment rate (%, max)2
6.1
(4Q25)
8.3
(3Q25)
House price index (%, start-to-
trough)1
(4.5)
(1Q26)
(0.3)
(1Q25)
Inflation rate (YoY % change,
max)3
3.4
(4Q25)
2.6
(3Q25)
Central bank policy rate (%,
max)3
5.0
(1Q25)
3.2
(1Q25)
1Cumulative change to the lowest level of the series during the 20-quarter
projection.
2The highest projected unemployment in the scenario.
3Due to the calibration of inflation and interest rates in 2Q25, the table
shows lowest year-on-year percentage change in inflation and projected
policy rates as at 2Q25, and the highest rates as at 4Q24.
Downside 2 scenario (3Q25-2Q30)
UK
France
GDP level (%, start-to-trough)1
(5.5)
(4Q26)
(6.3)
(4Q26)
Unemployment rate (%, max)2
8.7
(4Q26)
10.8
(2Q27)
House price index (%, start-to-
trough)1
(26.8)
(2Q27)
(6.8)
(4Q26)
Inflation rate (YoY % change)3
(1.9)
(2Q26)
(0.4)
(3Q26)
Central bank policy rate (%)3
1.6
(3Q26)
(0.1)
(2Q26)
Downside 2 scenario 2025–2029 (as at 4Q24)
UK
France
GDP level (%, start-to-trough)1
(9.1)
(2Q26)
(7.9)
(2Q26)
Unemployment rate (%, max)2
8.4
(2Q26)
10.4
(1Q27)
House price index (%, start-to-
trough)1
(27.2)
(4Q26)
(14.0)
(2Q27)
Inflation rate (YoY % change,
max)3
10.1
(2Q25)
7.6
(2Q25)
Central bank policy rate (%,
max)3
5.5
(1Q25)
4.2
(1Q25)
1Cumulative change to the lowest level of the series during the 20-quarter
projection.
2The highest projected unemployment in the scenario.
3Due to the calibration of inflation and interest rates in 2Q25, the table
shows lowest year-on-year percentage change in inflation and projected
policy rates as at 2Q25, and the highest rates as at 4Q24.
The following table describes the probabilities assigned in each
scenario.
Scenario weightings, %
Standard
weights
UK
France
2Q25
Upside
10
10
10
Central
75
65
65
Downside
10
20
20
Downside 2
5
5
5
4Q24
Upside
10
10
10
Central
75
75
75
Downside
10
10
10
Downside 2
5
5
5
IFRS 9 ECL sensitivity to future economic conditions
Reported
Gross
carrying
amount
Reported
allowance
for ECL
Consensus
Central
scenario
allowance
for ECL
Consensus
Upside
scenario
allowance
for ECL
Consensus
Downside
scenario
allowance
for ECL
Consensus
Downside 2
scenario
allowance
for ECL
At 30 Jun 2025
£m
£m
£m
£m
£m
£m
Corporate and commercial and NBFIs1,2,3
339,565
173
158
135
222
355
–  of which: UK
132,667
34
31
26
62
101
–  of which: France
141,818
93
87
76
106
141
Mortgages4
4,403
56
56
55
56
62
–  of which: UK
1,969
2
2
2
2
4
Credit cards and other retail4
68
1
1
1
1
1
At 31 Dec 2024
Corporate and commercial and NBFIs1,2,3
347,588
165
155
130
192
552
–  of which: UK
139,207
39
35
25
50
284
–  of which: France
145,484
64
63
55
76
99
Mortgages4
4,479
67
66
66
67
74
–  of which: UK
1,979
2
2
2
2
4
Credit cards and other retail4
68
1
1
1
1
1
1Allowance for ECL sensitivity includes off-balance sheet financial instruments. These are subject to significant measurement uncertainty.
2Includes low credit-risk financial instruments such as debt instruments at FVOCI, which have high carrying amounts but low ECL under all the above scenarios.
3Excludes defaulted obligors.
4Allowance for ECL sensitivities exclude portfolios utilising less complex modelling approaches.
Compared with 31 December 2024, the Downside 2 ECL impact decreased, mostly in the UK due to new PD models. These models include a
recent calibration of credit risk experience under a higher interest rate environment, and result in a reduction of sensitivity to severe stress
under similar conditions.
Disclosure of reconciliation of changes in loss allowance and explanation of changes in gross carrying amount for financial instruments
Management judgemental adjustments to ECL at 30 Jun 20251
Retail
Wholesale2
Total
£m
£m
£m
Modelled ECL (A)3
110
111
221
Corporate lending adjustments
21
21
Other credit judgements
11
39
50
Total management judgemental
adjustments (B)4
11
60
71
Other adjustments (C)5
6
6
Final ECL (A+B+C)6
127
171
298
Management judgemental adjustments to ECL at 31 Dec 20241
Retail
Wholesale2
Total
£m
£m
£m
Modelled ECL (A)3
125
154
279
Corporate lending adjustments
25
25
Other credit judgements
9
(13)
(4)
Total management judgemental
adjustments (B)4
9
12
21
Other adjustments (C)5
(15)
(15)
Final ECL (A+B+C)6
119
166
285
1Management judgemental adjustments presented in the table reflect
increases or (decreases) in allowance for ECL, respectively.
2The wholesale portfolio corresponds to adjustments to the performing
portfolio (stage 1 and stage 2).
3(A) refers to probability-weighted allowance for ECL before any adjustments
are applied.
4(B) refers to adjustments that are applied where management believes
allowance for ECL does not sufficiently reflect the credit risk/expected
credit loses of any given portfolio at the reporting date. These can relate to
risks or uncertainties that are not reflected in the model and/or to any late-
breaking events.
5(C) refers to adjustments to allowance for ECL made to address process
limitations and data/model deficiencies and can also include, where
appropriate, the impact of new models where governance has sufficiently
progressed to allow an accurate estimate of ECL allowance to be
incorporated into the total reported ECL.
6As presented within our internal credit risk governance (see page 31 of the
Annual Report and Accounts 2024).
Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan
commitments and financial guarantees1
(Reviewed)
Non-credit impaired
Credit impaired
Stage 1
Stage 2
Stage 3
POCI
Total
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
At 1 Jan 2025
177,176
(74)
10,494
(133)
2,302
(694)
41
(18)
190,013
(919)
Transfers of financial
instruments:
834
(23)
(987)
25
156
(2)
3
–  transfers from stage 1 to
stage 2
(4,377)
4
4,377
(4)
–  transfers from stage 2 to
stage 1
5,318
(27)
(5,318)
27
–  transfers to stage 3
(111)
(149)
9
262
(9)
2
–  transfers from stage 3
4
103
(7)
(106)
7
1
Net remeasurement of ECL
arising from transfer of stage
21
(15)
6
Net new and further lending/
repayments
(449)
(6)
(1,551)
20
(341)
13
1
(2,340)
27
Changes to risk parameters –
credit quality
(11)
(47)
(64)
(1)
(123)
Changes to model used for ECL
calculation
6
29
35
Assets written off
(259)
259
(259)
259
Foreign exchange
3,456
1
231
(1)
46
(9)
3,733
(9)
Others2,3,4
(4,006)
(1)
(153)
2
(19)
(1)
1
(4,178)
1
At 30 Jun 2025
177,011
(87)
8,034
(120)
1,885
(498)
42
(18)
186,972
(723)
ECL income statement change
for the period
10
(13)
(51)
(1)
(55)
Recoveries
1
Others
(22)
Total ECL income statement
change for the period
(76)
Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan
commitments and financial guarantees1
At 30 Jun 2025
Half-year ended
30 Jun 2025
Gross carrying/
nominal amount
Allowance
for ECL
ECL
charge
 
£m
£m
£m
As above
186,972
(723)
(76)
Other financial assets measured at amortised cost
244,062
(6)
Non-trading reverse purchase agreement commitments
56,861
Performance and other guarantee not considered for IFRS 9
2
Summary of financial instruments to which the impairment requirements in IFRS 9 are applied/
Summary consolidated income statement
487,895
(729)
(74)
Debt instruments measured at FVOCI
52,547
(26)
(1)
Total allowance for ECL/total income statement ECL change for the period
N/A
(755)
(75)
1Excludes performance guarantee contracts to which the impairment requirements in IFRS 9 are not applied.
2Includes the period on period movement in exposures relating to other HSBC Group companies. At 30 June 2025, this amount increased by £2.1bn and was
classified as stage 1 with no ECL.
3Total includes £0.7bn of gross carrying loans and advances to customers and banks, which were classified to assets held for sale, reflecting business disposals
as disclosed in Note 11: ‘Assets held for sale and liabilities of disposal groups held for sale’ on page 48.
4This includes £5.6bn of gross carrying loans and advances to customers and corresponding allowance for ECL of £6m in relation to France retail portfolio of
home and certain other loans, which were classified to assets held for sale in 1H25, reflecting business disposals as disclosed in Note 11: ‘Assets held for sale
and liabilities of disposal groups held for sale’ on page 48.
Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan
commitments and financial guarantees1 (continued)
(Reviewed)
Non-credit impaired
Credit Impaired
Stage 1
Stage 2
Stage 3
POCI
Total
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
Gross
carrying/
nominal
amount
Allowance
for ECL
£m
£m
£m
£m
£m
£m
£m
£m
£m
£m
At 1 Jan 2024
162,228
(91)
15,445
(147)
2,556
(903)
35
(6)
180,264
(1,147)
Transfers of financial instruments:
2,460
(42)
(3,223)
47
763
(5)
–  transfers from stage 1 to stage 2
(7,440)
8
7,440
(8)
–  transfers from stage 2 to stage 1
10,182
(48)
(10,182)
48
–  transfers to stage 3
(390)
1
(649)
13
1,039
(14)
–  transfers from stage 3
108
(3)
168
(6)
(276)
9
Net remeasurement of ECL arising from
transfer of stage
29
(22)
7
Net new and further lending/repayments
10,816
7
(1,409)
3
(635)
322
6
(7)
8,778
325
Changes to risk parameters – credit quality
23
(31)
(504)
(5)
(517)
Changes to model used for ECL calculation
(1)
17
16
Assets written off
(257)
255
(257)
255
Foreign exchange
(4,916)
2
(345)
2
(83)
24
(5,344)
28
Others2
6,588
(1)
26
(2)
(42)
117
6,572
114
At 31 Dec 2024
177,176
(74)
10,494
(133)
2,302
(694)
41
(18)
190,013
(919)
ECL income statement change for the
period
58
(33)
(182)
(12)
(169)
Recoveries
2
Others
13
Total ECL income statement change for the
period
(154)
Reconciliation of changes in gross carrying/nominal amount and allowances for loans and advances to banks and customers including loan
commitments and financial guarantees1 (continued)
At 31 Dec 2024
12 months ended
31 Dec 2024
Gross carrying/
nominal amount
Allowance
for ECL
ECL
charge
£m
£m
£m
As above
190,013
(919)
(154)
Other financial assets measured at amortised cost
237,475
(6)
(6)
Non-trading reverse purchase agreement commitments
32,675
Performance and other guarantees not considered for IFRS 9
(2)
Summary of financial instruments to which the impairment requirements in IFRS 9 are applied/
Summary consolidated income statement
460,163
(925)
(162)
Debt instruments measured at FVOCI
46,649
(22)
(1)
Total allowance for ECL/total income statement ECL change for the period
N/A
(947)
(163)
1Excludes performance guarantee contracts to which the impairment requirements in IFRS 9 are not applied.
2Includes the period on period movement in exposures relating to other HSBC Group companies. At 31 December 2024, these amounted to £0.77bn and were
classified as stage 1 with no ECL.
Own funds disclosure
Own funds disclosure
At
30 Jun 2025
31 Dec 2024
Ref*
£m
£m
6
Common equity tier 1 capital before regulatory adjustments
23,442
23,064
28
Total regulatory adjustments to common equity tier 1
(1,602)
(1,168)
29
Common equity tier 1 capital
21,840
21,896
36
Additional tier 1 capital before regulatory adjustments
4,119
3,932
44
Additional tier 1 capital
4,119
3,932
45
Tier 1 capital
25,959
25,828
51
Tier 2 capital before regulatory adjustments
15,014
15,835
57
Total regulatory adjustments to tier 2 capital
(361)
(357)
58
Tier 2 capital
14,653
15,478
59
Total capital
40,612
41,306
Capital ratios
%
%
61
Common equity tier 1 (as a percentage of total risk exposure amount)
19.38
19.51
62
Tier 1 (as a percentage of total risk exposure amount)
23.03
23.01
63
Total capital (as a percentage of total risk exposure amount)
36.03
36.80
*These are references to lines prescribed in the Pillar 3 ‘Own funds disclosure’ template.
Disclosure of value at risk The trading VaR for the half-year to 30 June 2025 is shown in the table below.
Trading VaR, 99% 1 day
Foreign exchange
(‘FX’) and commodity
Interest
rate (‘IR’)
Equity
(‘EQ’)
Credit spread
(‘CS’)
Portfolio
diversification1
Total2
£m
£m
£m
£m
£m
£m
Half-year to 30 Jun 2025
7.5
7.4
10.5
9.0
(15.0)
19.4
Average
9.3
11.2
11.1
6.6
(14.7)
23.5
Maximum
20.1
19.2
15.3
11.0
32.3
Minimum
3.8
6.0
8.6
3.8
16.3
Half-year to 30 Jun 2024
10.0
15.0
10.7
7.0
(16.5)
26.2
Average
8.1
21.4
9.5
7.4
(18.4)
27.9
Maximum
14.8
27.8
11.5
9.3
37.2
Minimum
4.2
12.6
8.1
4.5
18.7
Half-year to 31 Dec 2024
6.9
11.2
12.6
4.6
(13.5)
21.8
Average
8.5
13.7
11.3
5.7
(14.7)
24.5
Maximum
14.8
23.9
13.4
7.7
36.1
Minimum
4.5
7.8
9.1
4.1
18.5
1Portfolio diversification is the market risk dispersion effect of holding a portfolio containing different risk types. It represents the reduction in unsystematic
market risk that occurs when combining a number of different risk types, for example, interest rate, equity and foreign exchange, together in one portfolio. It is
measured as the difference between the sum of the VaR by individual risk type and the combined total VaR. A negative number represents the benefit of
portfolio diversification. As the maximum occurs on different days for different risk types, it is not meaningful to calculate a portfolio diversification benefit for
this measure.
2The Total VaR is non-additive across risk types due to diversification effect and it includes “Risks Not in VaR” (“RNIV”) add-ons.
The non-trading VaR for the half-year to 30 June 2025 is shown in the table below.
Non-trading VaR, 99% 10 day
Interest rate
('IR')
Credit spread
('CS')
Portfolio
diversification1
Total2
£m
£m
£m
£m
Half-year to 30 Jun 2025
88.1
41.9
(6.0)
123.9
Average
89.1
42.9
(3.7)
128.3
Maximum
115.9
45.7
147.2
Minimum
75.0
41.4
113.2
Half-year to 30 Jun 2024
128.4
36.9
(40.1)
125.3
Average
143.6
36.3
(37.6)
142.4
Maximum
202.3
42.0
216.3
Minimum
66.2
29.6
70.0
Half-year to 31 Dec 2024
101.0
41.1
(8.4)
133.7
Average
85.2
39.7
(25.7)
99.1
Maximum
131.9
57.7
133.7
Minimum
41.5
29.1
54.8
1Portfolio diversification is the market risk dispersion effect of holding a portfolio containing different risk types. It represents the reduction in unsystematic
market risk that occurs when combining a number of different risk types, for example, interest rate, equity and foreign exchange, together in one portfolio. It is
measured as the difference between the sum of the VaR by individual risk type and the combined total VaR. A negative number represents the benefit of
portfolio diversification. As the maximum occurs on different days for different risk types, it is not meaningful to calculate a portfolio diversification benefit for
this measure.
2The total VaR is non-additive across risk types due to diversification effect.
Additional information about insurance contracts The following table shows the composition of assets and liabilities by contract type.
Balance sheet of insurance manufacturing subsidiaries by type of contract
Life direct participating
and investment DPF
contracts1
Life
other2
Other
contracts3
Shareholder
assets
and liabilities
Total
£m
£m
£m
£m
£m
Financial assets
4,010
45
1,021
429
5,505
–  financial assets designated and otherwise mandatorily measured at
fair value through profit or loss
3,506
30
1,014
363
4,913
–  derivatives
8
8
–  financial investments – at amortised cost
2
2
–  financial assets at fair value through other comprehensive income
–  other financial assets4
496
15
7
64
582
Insurance contract assets
45
45
Reinsurance contract assets
132
132
Other assets and investment properties5
19,149
1
4
1,257
20,411
Total assets at 30 Jun 2025
23,159
223
1,025
1,686
26,093
Liabilities under investment contracts designated at fair value
1,074
1,074
Insurance contract liabilities
3,452
255
3,707
Reinsurance contract liabilities
29
29
Deferred tax
8
8
Other liabilities5
18,165
31
1,891
20,087
Total liabilities
21,617
315
1,074
1,899
24,905
Total equity
1,188
1,188
Total liabilities and equity at 30 Jun 2025
21,617
315
1,074
3,087
26,093
Financial assets
3,749
48
1,026
421
5,244
–  financial assets designated and otherwise mandatorily measured at
fair value through profit or loss
3,223
32
1,018
365
4,638
–  derivatives
5
5
–  financial investments – at amortised cost
1
1
–  financial assets at fair value through other comprehensive income
–  other financial assets4
521
16
8
55
600
Insurance contract assets
38
38
Reinsurance contract assets
132
132
Other assets and investment properties5
18,229
1
1,176
19,406
Total assets at 31 Dec 2024
21,978
219
1,026
1,597
24,820
Liabilities under investment contracts designated at fair value
1,078
1,078
Insurance contract liabilities
3,165
259
3,424
Reinsurance contract liabilities
38
38
Deferred tax
9
9
Other liabilities
17,355
32
1,761
19,148
Total liabilities
20,520
329
1,078
1,770
23,697
Total equity
1,123
1,123
Total liabilities and equity at 31 Dec 2024
20,520
329
1,078
2,893
24,820
1‘Life direct participating and investment DPF’ contracts are substantially measured under the variable fee approach measurement model.
2‘Life other’ mainly includes protection type contracts as well as reinsurance contracts. The reinsurance contracts primarily provide diversification benefits over
the life participating and investment discretionary participation feature ('DPF') contracts.
3‘Other contracts’ includes investment contracts for which HSBC does not bear significant insurance risk.
4‘Other financial assets’ comprise mainly loans and advances to banks, cash and inter-company balances with other non-insurance legal entities.
5‘Other assets and investment properties’ includes £20,338m (31 December 2024: £19,309m) and ‘Other liabilities’ includes £19,606m (31 December 2024:
£18,668m) in respect of the classification of the French life insurance business to held for sale. Further details are provided on page 48.